Article
Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
Malaria journal - 21 May 2010
Afonso Ana, Neto Zoraima, Castro Helena, Lopes Dinora, Alves Ana C, Tomás Ana M, Rosário Virgílio D
Abstract excerpt
BACKGROUND: Plasmodium falciparum, has developed resistance to many of the drugs in use. The recommended treatment policy is now to use drug combinations. The atovaquone-proguanil (AP) drug combination, is one of the treatment and prophylaxis options. Atovaquone (ATQ) exerts its action by inhibiting plasmodial mitochondria electron transport at the level of the cytochrome bc1 complex. Plasmodium falciparum in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
